Form D · Other Health Care
Alto Pharmacy Holdings, Inc.
San Francisco, CA · CIK 0001841543
Offering snapshot reported Jan 28, 2022 · SEC filing
- Reported sold
- $132M Offering amount: $162M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 14, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 28, 2022 | Initial | $132,179,991 | No comparison | 18 | SEC filing |
| Nov 2, 2021 | Initial | $36,430,000 | No comparison | 7 | SEC filing |
| Jan 26, 2021 | Initial | $1,042,723 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-431248
Source: Form D, filed Jan 28, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Burns | Director, Executive |
| Nichola Eliovits | Director |
| Mattieu Gamache Asselin | Director |
| Nathaniel Kan | Director |
| James Karraker | Director |
| Neil Shah | Director |
| Robert Spinner | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
645 Harrison St. Suite 200
San Francisco, CA, 94107
San Francisco, CA, 94107